Latest / RegulatingAI Podcast: Innovate Responsibly
AI's Role in Accelerating Drug Development and Clinical Trials with Raphael Townshend, PhD, Founder and CEO of Atomic AI
AI and RNA are revolutionizing drug discovery, promising a future where life-saving medications are developed faster and at lower costs.
In this episode, Raphael Townshend, PhD, Founder and CEO of Atomic AI, sits down with me to discuss the intersection of AI and RNA in drug development. We explore how AI technologies can reduce the cost and time required for clinical trials and target previously incurable diseases.
Key Takeaways:
(02:15) Raphael's background in AI and biology, and founding of Atomic AI.
(05:59) Reducing time and failure rate in drug discovery with AI.
(07:16) AlphaFold's…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.